J-trx opt/mkt Flashcards Preview

Work > J-trx opt/mkt > Flashcards

Flashcards in J-trx opt/mkt Deck (9)
Loading flashcards...
1
Q

Factors that Influence Treament

A
  • Specific pathogen causing onychomycosis
  • potential adverse events associated with trx
  • Potential drug interactions
  • Dosage schedule and patients lifestyle
  • patient compliance
  • Cost
  • age/health of patient
2
Q

Mechanical Trx

A

Debridement, avulsion and laser therapy

3
Q

Debridement

A

removal of foreign material and dead or damaged tissue

4
Q

Avulsion

A

Removal of all or part of the nail plate

5
Q

OTC

A

Formula 3/Proclearz (1% tolnaftate) - mild fungicidal/antifungal

Lotrimin (Clotrimazole 1%) -Antifungal spec for yeast

6
Q

Oral Antifungal Agents

A

Highest rates of complete/mycological cure
Primary concern is potential drug interaction and adverse events including liver.

ie. terbinafine (3-4 month therapy)and itraconazole (12wk therapy)

7
Q

Topical Antifungal Agents

A

Primary therapy in mild infectiosn
Pallative therapy for those unable to take oral
Prophylactic therapy to help prevent infection

ie Penlac (Ciclopirox) 
    Kerydin (tavaborole)
8
Q

Lamisil ( Terbinafine)

A

250mg tablet
1x a day for 12wks

Warnings-Hepatoxicity

9
Q

Penlac ( Ciclopirox)

A

Lacquer solution in 6.6ml bottle w/screw caps wit brush
mild to mod infection
daily for 48wks